Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers

Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers

US Patent 11406627 · Granted Aug 9, 2022

Estimated economic value: $37,129,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic combinations comprising a c-RAF inhibitor2024
Pharmaceutical combinations2022
Therapeutic uses of a C-RAF inhibitor2021
Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical 2020
Combination therapy2020
Pharmaceutical combinations2019
Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the B-RAF2019
Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the CDK4/2019
Pharmaceutical combinations2019
Androgen receptor mutation2018
Combination therapy2018
Pharmaceutical combination comprising binimetinib2018